camptothecin-20-o-propionate hydrate
Small moleculeexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2008 (NCT02575638)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Topoisomerase IINHIBITOR
Topoisomerase I inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- camptothecin-20-o-propionate hydrate
- cz48
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00947739 | Phase 1 | Sep 1, 2008 | Christus Stehlin Foundation for Cancer Research, New Mexico Cancer Care Alliance, University of New Mexico |
| NCT02575638 | Phase 1 | Jul 1, 2008 | Cao Pharmaceuticals Inc., University of Texas, San Antonio |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cao Pharmaceuticals Inc. | For profit | 1 | 1 | 1 | 2008 |
| Christus Stehlin Foundation for Cancer Research | Academic/Hospital | 1 | 0 | 1 | 2008 |
| New Mexico Cancer Care Alliance | Academic/Hospital | 1 | 1 | 1 | 2008 |
| University of New Mexico | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Texas, San Antonio | Academic/Hospital | 1 | 0 | 1 | 2008 |
5 organizations
Page 1 / 1